Comprehensive Pharmacology and Drug Therapy for Nursing Practice

0.0(0)
studied byStudied by 0 people
call kaiCall Kai
learnLearn
examPractice Test
spaced repetitionSpaced Repetition
heart puzzleMatch
flashcardsFlashcards
GameKnowt Play
Card Sorting

1/251

encourage image

There's no tags or description

Looks like no tags are added yet.

Last updated 12:07 AM on 2/6/26
Name
Mastery
Learn
Test
Matching
Spaced
Call with Kai

No analytics yet

Send a link to your students to track their progress

252 Terms

1
New cards

Drug

any chemical that can affect living processes

2
New cards

Pharmacology

study of drugs and their interactions with living systems (animals, plants)

3
New cards

Pharmacotherapeutics

the use of drugs to diagnose, prevent, or treat disease or to prevent pregnancy

4
New cards

Brand Name

A drug sold by a drug company under a specific name or trademark and that is protected by a patent

5
New cards

Generic Name

a prescription drug that has the same active ingredients as the brand name

6
New cards

Effectiveness

ability of a drug to produce a desired effect - most important property a drug can have

7
New cards

Safety

drug can not produce harmful effects

8
New cards

Selectivity

drug produces only the response for which it is given

9
New cards

Therapeutic Effect

the desirable and intended outcome or response from a drug

10
New cards

Maximum Benefit with Minimal Harm

the ideal outcome for a response by having a maximum positive effect while minimizing any potential risks associated with that specific drug therapy

11
New cards

10 Rights of Medication Administration

Right drug, Right route, Right Patient, Right Dose, Right Time, Right Assessment, Right Documentation, Right Evaluation, Right of patient education, Right of patient to refuse care

12
New cards

Preclinical Testing

Testing for 1-5 yrs on animals before applying to FDA for human testing permissions

13
New cards

Clinical Testing

4 phases encompassing 2-10 yrs

14
New cards

Phase 1

healthy volunteers typically unless severe side effects as in cancer drugs etc. 3 goals: Evaluate drug metabolism, Pharmacokinetics, Biologic effects

15
New cards

Phases 2&3

Patients utilized to determine therapeutic effects, dosage range, safety, and effectiveness. 500-5000 pt's receive the drug and only a few hundred take it for more than 3-6 months

16
New cards

Phase 4

Postmarketing Surveillance - Drug is released for general use, permitting observation of its effects in a large population

17
New cards

FDAAA of 2007

increased effectiveness of postmarketing surveillance

18
New cards

Pharmacokinetics

the study of drug movement throughout the body

19
New cards

Pharmacodynamics

study of biochemical and physiological effects of drugs on the body and the molecular mechanisms by which those effects are produced

20
New cards

Absorption

Movement of drug from its site of administration into the blood.

21
New cards

Factors affecting Absorption

Rate of dissolution, Surface area, Blood flow, Lipid solubility, pH partitioning, Distribution, Metabolism.

22
New cards

Metabolism

How the body converts medication into a less, or more active form (these forms are also known as metabolites).

23
New cards

Liver

Most drug metabolism takes place in the liver.

24
New cards

Hepatic microsomal enzyme system

Also known as the p450 system, it performs drug metabolism.

25
New cards

First-pass effect

A drug that undergoes rapid hepatic metabolism is often administered parenterally.

26
New cards

Enterohepatic recirculation

Drugs can remain in the body much longer than they otherwise would.

27
New cards

Excretion

Drugs and their metabolites can exit the body in urine, bile, sweat, saliva, breast milk, and expired air.

28
New cards

Kidney

Most important organ for drug excretion.

29
New cards

Intravenous Administration

Advantages include Rapid Onset, Precise Control, Permits use of large fluid volumes, Permits use of irritant drugs.

30
New cards

Disadvantages of Intravenous Administration

High Cost, Difficulty, Inconvenience, Irreversibility.

31
New cards

Intramuscular and Subcutaneous Administration

Rate of absorption is determined by blood flow and drug solubility.

32
New cards

Advantages of Intramuscular and Subcutaneous Administration

No significant barriers (only barrier is capillary wall), Suitable for poorly soluble drugs and depot preparations.

33
New cards

Disadvantages of Intramuscular and Subcutaneous Administration

Discomfort, Inconvenience, Potential for injury.

34
New cards

Oral Administration

Barriers include a layer of epithelial cells and capillary wall.

35
New cards

Absorption Pattern in Oral Administration

Multiple factors affect absorption.

36
New cards

Advantages of Oral Administration

Easy and Convenient.

37
New cards

Plasma drug level

The minimum effective concentration (MEC) is defined as the plasma drug level below which therapeutic effects will not occur.

38
New cards

Toxic concentration

The plasma level at which toxic effects begin.

39
New cards

Therapeutic Range

Plasma drug levels falling between the MEC and the toxic concentration.

40
New cards

Narrow therapeutic range

Drugs that have a narrow therapeutic range are less safe.

41
New cards

Wide therapeutic range

Drugs that have a wide therapeutic range can be administered safely with relative ease.

42
New cards

Drug-receptors

Receptors are any functional macromolecule in a cell to which a drug binds to produce its effects.

43
New cards

Dose-response relationships

Relationship between the size of an administered dose and the intensity of the response produced.

44
New cards

Relative potency

The amount of drug we must give to elicit an effect.

45
New cards

Maximal efficacy

The largest effect that a drug can produce.

46
New cards

Interpatient variability

The dose required to produce a therapeutic response can vary substantially from patient to patient.

47
New cards

ED50

The dose that is required to produce a defined therapeutic response in 50% of the population.

48
New cards

LD50

The dose that is lethal to 50% of the animals treated.

49
New cards

Therapeutic index

A measure of a drug's safety.

50
New cards

Drug-drug interactions

Interactions that can occur from multiple drug ingestion, often when patients take a variety of drugs throughout the day.

<p>Interactions that can occur from multiple drug ingestion, often when patients take a variety of drugs throughout the day.</p>
51
New cards

Consequences of drug-drug interactions

Include intensification of therapeutic effects, reduction of therapeutic effects, and/or creation of a unique response.

52
New cards

Grapefruit juice effect

Inhibits metabolism of certain drugs, raising blood levels, but does not affect IV drugs.

53
New cards

MAOIs + tyramine

Can cause life-threatening hypertension.

54
New cards

Potassium sparing diuretics

Can have toxic effects when combined with salt substitutes.

55
New cards

Aluminum containing antacids

Can have toxic effects when combined with citrus beverages.

56
New cards

Timing of administration

Some drugs are better taken on an empty stomach, while others should be taken with food.

57
New cards

Drug-herb interactions

Conventional drugs can interact with herbal preparations, but reliable information is often lacking.

58
New cards

Pharmacokinetic interaction

Altered absorption, distribution, renal excretion, or metabolism of drugs.

59
New cards

Altered absorption

Can be caused by elevated gastric pH, laxatives, or drugs that depress peristalsis.

60
New cards

Altered distribution

Can occur due to competition for protein binding and alteration of extracellular fluid pH.

61
New cards

Altered renal excretion

Drugs can alter filtration, reabsorption, and active secretion.

62
New cards

Altered metabolism

Can increase the rate of metabolism 2-3 fold over 7-10 days.

63
New cards

Pharmacodynamic drug-drug interactions

Interactions that occur at the same receptor, often resulting in inhibitory effects.

64
New cards

Combined toxicity

Drugs with overlapping toxicities should not be used together.

65
New cards

Minimum drug concentration

The amount of drug at a minimum which will have efficacy.

66
New cards

Drug half-life

The time required for the amount of drug in the body to decrease by 50%.

67
New cards

Drug plateau

When there is a steady level of drugs in the body.

68
New cards

Potency

Refers to the amount of drug required to elicit an effect.

69
New cards

Agonists

Molecules that activate receptors.

70
New cards

Antagonists

Produce effects by preventing receptor activation by endogenous regulatory molecules and drugs.

71
New cards

Affinity

The attraction between a drug and its receptor.

72
New cards

Intrinsic activity

The ability of a drug to activate a receptor.

73
New cards

Side Effect

A nearly unavoidable secondary drug effect produced at therapeutic doses.

74
New cards

Adverse Effect

Unexpected effects, severe response!

75
New cards

Toxicity

The degree of harmful physiological effects caused by excessive drug dosing.

76
New cards

Allergic reaction

An immune response.

77
New cards

Synergistic effect

Two drugs given together have a greater impact than when given alone.

78
New cards

Idiosyncratic effect

An uncommon drug response resulting from a genetic predisposition.

79
New cards

Paradoxical effect

Opposite of the intended drug response.

80
New cards

Iatrogenic disease

Disease that occurs as the result of medical care or treatment. The term is also used to denote a disease produced by drugs.

81
New cards

Physical dependence

The body has adapted to drug exposure in such a way that an abstinence syndrome will result if drug use is discontinued.

82
New cards

Carcinogenic effect

The ability of certain medications and environmental chemicals to cause cancers.

83
New cards

Teratogenic effect

A drug-induced birth defect.

84
New cards

Types of Medication Errors

Wrong patient, Wrong drug, Wrong route, Wrong time, Wrong dose, Omitted dose, Wrong dosage form, Wrong diluent, Wrong strength/concentration, Wrong infusion rate, Wrong technique, Deteriorated drug error, Wrong duration of treatment.

85
New cards

Ways to Reduce Medication Errors

Institutional Culture, Infrastructure, Clinical Practice, Technology.

86
New cards

How to Report Medication Errors

MER program: nationwide system run by ISMP reporting done online or via phone and is confidential. All information gathered by MER program is forwarded to FDA, the ISMP, and the product manufacturer.

87
New cards

Individual variation

Factors affecting drug responses including body weight, composition, genetics, gender, race, age.

88
New cards

Body Weight and Composition

Body surface area versus weight.

89
New cards

Age

Significant variability with age; infants and older patients especially sensitive to drugs.

90
New cards

Pathophysiology

Includes Kidney Disease, Liver Disease, Acid-Base Imbalance, Altered Electrolyte Status.

91
New cards

Tolerance

When a patient becomes tolerant to a drug, the dosage must be increased to maintain beneficial effects.

92
New cards

Placebo Effect

A beneficial effect produced by a placebo treatment.

93
New cards

Variability in Absorption

Differences in how drugs are absorbed in individuals.

94
New cards

Genetics

Genetic factors that can influence drug response.

95
New cards

Gender- and Race-Related Variations

Differences in drug response based on gender and race.

96
New cards

Comorbidities and Drug Interaction

The presence of multiple conditions that can affect drug response.

97
New cards

Diet

Nutritional factors that can influence drug metabolism and response.

98
New cards

Failure to Take Medicine as Prescribed

Not adhering to the prescribed medication regimen.

99
New cards

Kidney Disease

Reduced excretion and increased toxicity.

100
New cards

Liver Disease

Reduced metabolism and increased toxicity.